产品编号 :
Cas No. :
CAS No. |
1258391-13-7 |
|---|---|
中文名称 |
HG-7-85-01 |
英文名称 |
HG-7-85-01 |
别名 |
HG-7-85-01;3-[2-(cyclopropanecarbonylamino)-[1,3]thiazolo[5,4-b]pyridin-5-yl]-N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide;Benzamide, 3-[2-[(cyclopropylcarbonyl)amino]thiazolo[5,4-b]pyridin-5-yl]-N-[4-[(4-ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]- |
标准英文名 |
3-(2-(cyclopropanecarboxamido)thiazolo[5,4-b]pyridin-5-yl)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide |
分子式 |
C31H31F3N6O2S |
分子量 |
608.69 |
精确分子量 |
608.22 |
SMILES |
O=C(NC1=CC=C(CN2CCN(CC)CC2)C(C(F)(F)F)=C1)C3=CC=CC(C4=CC=C5C(SC(NC(C6CC6)=O)=N5)=N4)=C3 |
标准SMILES |
CCN1CCN(CC2=CC=C(C=C2C(F)(F)F)NC(=O)C2C=C(C=CC=2)C2=CC=C3N=C(NC(=O)C4CC4)SC3=N2)CC1 |
用途 |
HG-7-85-01 is used as a type II ATP-competitive inhibitor of wild-type and gatekeeper mutant forms of Bcr-Abl, PDGFRα, Kit, and Src kinases; it inhibits T315I mutant Bcr-Abl, VEGFR2/KDR/Flk-1, and RET with IC50 values of 3 nM, 20 nM, and 30 nM, respectively, while showing minimal or no inhibition against other kinases (IC50 > 2 μM); it suppresses cell proliferation by inducing apoptosis and inhibiting cell cycle progression. |
InChIKey |
VTWWRKFUHCSCEW-UHFFFAOYSA-N |
|
|
评论 |
|---|